In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended ...

Biologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults ...

Excitingly, real benefits for patients are starting to emerge, particularly for patients with psoriasis. This collection of Research and Review-type articles highlights the role of the IL-17 ...

Psoriasis results from cross-talk between immune cells and keratinocytes in the skin. The nature of these signals now comes to light, revealing potential roles for IL-23 and a T H 17 response.

One of the most recent and perhaps most promising developments in psoriasis research is the role of the Th17 CD4 + T cell and one of its cytokines, IL-17, in disease development, progression and ...

Posters presented at the 2025 American Academy of Dermatology Annual Meeting found bimekizumab to have benefits beyond safety ...

Researchers from Anew Therapeutics Pte Ltd. recently detailed the discovery of novel oral IL-17A small-molecule inhibitors as candidates for the treatment of psoriasis.

becoming the first IL-17 drug to outperform another in the same class in psoriasis. UCB puts the performance of its drug down to its ability to inhibit both IL-17A and IL-17F, while Cosentyx only ...

in the treatment of adults with moderate-to-severe psoriasis, and according to UCB is the first study to compare IL-17 drugs directly in this setting. Bimekizumab performed better than Cosentyx ...

Until about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an idea of how much the field has changed, clinical guidelines on psoriasis ...

Psoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or IL-23 inhibitors compared with those receiving tumor necrosis factor (TNF ...

A recent review highlights how the Mediterranean diet can reduce inflammation and improve outcomes for chronic skin ...